PI
CDLX icon

PEAK6 Investments’s Cardlytics CDLX Stock Holding History

PEAK6 Investments’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,820
Closed -$698K – 3631
2024
Q1 		$698K Buy
+4,820
New +$407K ﹤0.01% 2203
2021
Q3 		– Sell
-460
Closed -$584K – 5219
2021
Q2 		$584K Buy
+460
New +$519K ﹤0.01% 3085
2021
Q1 		– Sell
-2,730
Closed -$3.9M – 4888
2020
Q4 		$3.9M Buy
+2,730
New +$2.91M 0.01% 1271

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Investments's CDLX Position: Q2 2022 in Review

PEAK6 Investments sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 607 shares — an estimated $334K sold.

PEAK6 Investments first reported a position in CDLX in Q2 2021 and held it in 3 quarters. The position peaked at $874K in Q2 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • PEAK6 Investments reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • PEAK6 Investments sold 607 Cardlytics shares in Q2 2022, an estimated $334K.
  • PEAK6 Investments first reported a position in Cardlytics in Q2 2021 and held it in 3 quarters.
  • PEAK6 Investments's Cardlytics position peaked at $874K in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.